Skip to content
TrialScanner

NCT00528684

Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant Gliomas

Phase 1CompletedONCYLead

Registry record

Lead sponsor
Oncolytics Biotech
Conditions
Malignant Glioma
Primary completion
Apr 2010Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT00528684 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT00528684: Safety and Efficacy Study of... | TrialScanner